Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
385.73
+7.37 (1.95%)
At close: Jul 28, 2026, 4:00 PM EDT
385.50
-0.23 (-0.06%)
After-hours: Jul 28, 2026, 7:39 PM EDT

Elevance Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
49,82649,49449,31150,08749,42148,76544,98944,71943,22342,27342,45442,48043,37741,89839,66739,62538,48237,88636,01835,548
Revenue Growth (YoY)
0.82%1.49%9.61%12.00%14.34%15.36%5.97%5.27%-0.36%0.90%7.03%7.21%12.72%10.59%10.13%11.47%15.63%18.03%14.22%15.98%
Cost of Revenue
42,51641,07843,58743,52041,99940,29539,51238,04235,39234,37136,17135,25435,93134,26733,84132,85831,86431,11430,53429,543
Gross Profit
7,3108,4165,7246,5677,4228,4705,4776,6777,8317,9026,2837,2267,4467,6315,8266,7676,6186,7725,4846,005
Selling, General & Admin
-------------------3,946
Depreciation & Amortization Expenses
110112164162147155180122162116217212221235247225166129135136
Other Operating Expenses
5,5476,3305,4155,2724,9975,3004,8045,2695,0664,8864,9995,4704,8184,8004,5674,5164,2724,345--
Total Operating Expenses
5,6576,4425,5795,4345,1445,4554,9845,3915,2285,0025,2165,6825,0395,0354,8144,7414,4384,4741354,082
Operating Income
1,6531,9741451,1332,2783,0154931,2862,6032,9001,0671,5442,4072,5961,0122,0262,1802,2985,3491,923
Interest Income
704765493625486590527551508465529493416387373371381360352335
Interest Expense
-364-357-366-351-341-344-340-300-280-265-259-259-261-251-229-213-208-201-200-201
Other Non-Operating Income (Expense)
-56-78-57-1-131-464-74-164155-161-336-124-121-113-111-57-231-151195-61
Total Non-Operating Income (Expense)
2843307027314-2181138738339-66110342333101-58834773
Pretax Income
1,9372,3042151,4062,2922,7976061,3732,9862,9391,0011,6542,4412,6191,0452,1272,1222,3061,4701,996
Provision for Income Taxes
483544-331219548613193365685690170354585615168529488527291494
Net Income
1,4541,7605461,1871,7442,1844131,0082,3012,2498311,3001,8562,0048771,5981,6341,7791,1791,502
Minority Interest in Earnings
-9-4-1-211-5-813-2511315--5-3-10-12-7
Net Income to Common
1,4631,7645471,1891,7432,1834181,0162,3002,2468561,2891,8531,9898651,6031,6371,7891,1911,509
Net Income Growth (YoY)
-16.06%-19.19%30.86%17.03%-24.22%-2.80%-51.17%-21.18%24.12%12.92%-1.04%-19.59%13.20%11.18%-27.37%6.23%-8.70%7.45%116.15%579.73%
Shares Outstanding (Basic)
217220222223225226231232232233236235237238241240241241246243
Shares Outstanding (Diluted)
218220222224226227231233233234236237238240241242243244246246
Shares Change (YoY)
-3.50%-2.99%-4.02%-4.03%-3.26%-2.99%-1.99%-1.44%-1.85%-2.30%-2.24%-2.35%-2.30%-1.92%-1.75%-1.54%-1.62%-1.53%-2.23%-3.23%
EPS (Basic)
6.748.032.475.327.749.641.814.389.919.653.635.487.838.373.596.696.807.414.636.20
EPS (Diluted)
6.718.002.475.327.729.611.814.369.859.593.635.457.798.303.596.626.737.324.636.13
EPS Growth (YoY)
-13.08%-16.75%36.46%22.02%-21.62%0.21%-50.14%-20.00%26.44%15.54%1.11%-17.67%15.75%13.39%-22.46%7.99%-7.17%9.09%111.42%604.60%
Free Cash Flow
1,6264,097-2097751,7878213842,3451241,699-3,2972,2941,6006,168-1,8164,6192,1572,2871,3322,246
Free Cash Flow Growth (YoY)
-9.01%399.03%--66.95%1341.13%-51.68%-2.22%-92.25%-72.45%--50.34%-25.82%169.70%-105.65%54.29%-0.61%-62.32%-
Free Cash Flow Per Share
7.4618.59-0.943.467.913.611.6610.060.537.25-13.989.706.7325.73-7.5319.078.869.365.439.13
Dividends Per Share
1.7201.7201.7101.7101.7101.7101.6301.6301.6301.6301.4801.4801.4801.4801.2801.2801.2801.2801.1301.130
Dividend Growth (YoY)
0.58%0.58%4.91%4.91%4.91%4.91%10.13%10.13%10.13%10.13%15.63%15.63%15.63%15.63%13.27%13.27%13.27%13.27%18.95%18.95%
Gross Margin
14.67%17.00%11.61%13.11%15.02%17.37%12.17%14.93%18.12%18.69%14.80%17.01%17.17%18.21%14.69%17.08%17.20%17.87%15.23%16.89%
Operating Margin
3.32%3.99%0.29%2.26%4.61%6.18%1.10%2.88%6.02%6.86%2.51%3.63%5.55%6.20%2.55%5.11%5.66%6.07%14.85%5.41%
Profit Margin
2.92%3.56%1.11%2.37%3.53%4.48%0.92%2.25%5.32%5.32%1.96%3.06%4.28%4.78%2.21%4.03%4.25%4.70%3.27%4.23%
FCF Margin
3.26%8.28%-0.42%1.55%3.62%1.68%0.85%5.24%0.29%4.02%-7.77%5.40%3.69%14.72%-4.58%11.66%5.61%6.04%3.70%6.32%
EBITDA
2,0192,3287501,5202,6583,3888911,6152,9383,2311,4911,9702,8403,0581,4852,4772,5732,6565,7092,274
EBITDA Margin
4.05%4.70%1.52%3.03%5.38%6.95%1.98%3.61%6.80%7.64%3.51%4.64%6.55%7.30%3.74%6.25%6.69%7.01%15.85%6.40%
EBIT
1,6531,9741451,1332,2783,0154931,2862,6032,9001,0671,5442,4072,5961,0122,0262,1802,2985,3491,923
EBIT Margin
3.32%3.99%0.29%2.26%4.61%6.18%1.10%2.88%6.02%6.86%2.51%3.63%5.55%6.20%2.55%5.11%5.66%6.07%14.85%5.41%
Effective Tax Rate
24.94%23.61%-153.95%15.58%23.91%21.92%31.85%26.58%22.94%23.48%16.98%21.40%23.97%23.48%16.08%24.87%23.00%22.85%19.80%24.75%
SEC Filings: 10-K · 10-Q